Stephen Samuel Opat

49PUBLICATIONS
203CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersLanguage documentation and descriptionTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|Sep 30, 2026
A phase 1, first-in-human study of safimaltib, a MALT1 inhibitor, in B-lymphocytic malignancies.

|Jul 17, 2026
End-of-treatment positron emission tomography/computed tomography complete remission is highly prognostic in nodal peripheral T-cell lymphoma: An Australasian-Canadian collaborative study.

|Jul 07, 2026
Australasian chronic lymphocytic leukaemia consensus statement: 2026 update.

|May 26, 2026
Significant variations in first-line mantle cell lymphoma care-an Australasian Lymphoma and Related Diseases Registry study.

|Mar 02, 2026
Fixed-duration VenO vs FCR/BR in fit patients with untreated CLL: primary analysis of the phase 3 CRISTALLO trial.

Jeff P Sharman, Luca Laurenti, Emmanuelle Ferrant

|Oct 29, 2025
Development and Validation of Prognostic Models for Treatment Response of Patients with B-Cell Lymphoma: Standard Statistical and Machine-Learning Approaches.

Adugnaw Zeleke Alem, Itismita Mohanty, Nalini Pati

Pageof 9

Frequent Collaborators

13 joint publications

Constantine Tam

9 joint publications

Judith Trotman

8 joint publications

Eliza A Hawkes

8 joint publications

Gareth Peter Gregory